NCT06640933View on ClinicalTrials.gov

A Study to Find Out How Different Forms of BIIB091 is Processed in The Body With and Without Food in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 16, 2024

Primary Completion Date

February 7, 2025

Study Completion Date

February 7, 2025

Conditions
Healthy Volunteer
Interventions
DRUG

BIIB091

Administered as specified in the treatment arm.

Trial Locations (2)

78744

PPD Clinical Research Unit, Austin

89113

PPD Las Vegas Research Unit, Las Vegas

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT06640933 - A Study to Find Out How Different Forms of BIIB091 is Processed in The Body With and Without Food in Healthy Participants | Biotech Hunter | Biotech Hunter